The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Neurofascin as a novel target for autoantibody-mediated axonal injury
Open accessAbstract
Axonal injury is considered the major cause of disability in patients with multiple sclerosis (MS), but the underlying effector mechanisms are poorly understood. Starting with a proteomics-based approach, we identified neurofascin-specific autoantibodies in patients with MS. These autoantibodies recognize the native form of the extracellular domains of both neurofascin 186 (NF186), a neuronal protein concentrated in myelinated fibers at nodes of Ranvier, and NF155, the oligodendrocyte-specific isoform of neurofascin. Our in vitro studies with hippocampal slice cultures indicate that neurofascin antibodies inhibit axonal conduction in a complement-dependent manner. To evaluate whether circulating antineurofascin antibodies mediate a pathogenic effect in vivo, we cotransferred these antibodies with myelin oligodendrocyte glycoprotein–specific encephalitogenic T cells to mimic the inflammatory pathology of MS and breach the blood–brain barrier. In this animal model, antibodies to neurofascin selectively targeted nodes of Ranvier, resulting in deposition of complement, axonal injury, and disease exacerbation. Collectively, these results identify a novel mechanism of immune-mediated axonal injury that can contribute to axonal pathology in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Weinshenker, B. G., O'Brien, P. C., Petterson, T. M., Noseworthy, J. H., Lucchinetti, C. F., Dodick, D. W., Pineda, A. A., Stevens, L. N., & Rodriguez, M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<878::aid-ana10>3.0.co;2-q · Cited by 894
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Self-citationMultiple sclerosis: a two-stage disease
Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 593
Bjartmar, C., Wujek, J. R., & Trapp, B. D. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00069-2 · Cited by 573
The role of nitric oxide in multiple sclerosis
Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531
Storch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 522
Self-citationColes, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506
Axonal pathology in multiple sclerosis: relationship to neurologic disability
Trapp, B. D., Ransohoff, R., & Rudick, R. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199906000-00008 · Cited by 475
Keegan, M., König, F., McClelland, R., Brück, W., Morales, Y., Bitsch, A., Panitch, H., Lassmann, H., Weinshenker, B., Rodriguez, M., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67102-4 · Cited by 433
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O'Connor, K. C., McLaughlin, K. A., De Jager, P. L., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar-Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 416
Kowal, C., DeGiorgio, L. A., Nakaoka, T., Hetherington, H., Huerta, P. T., Diamond, B., & Volpe, B. T. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.011 · Cited by 405
Davis, J. Q., Lambert, S., & Bennett, V (1996) · The Journal of cell biology · doi:10.1083/jcb.135.5.1355 · Cited by 347
Neurofascins Are Required to Establish Axonal Domains for Saltatory Conduction
Sherman, D. L., Tait, S., Melrose, S., Johnson, R., Zonta, B., Court, F. A., Macklin, W. B., Meek, S., Smith, A. J. H., Cottrell, D. F., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.019 · Cited by 342
Wilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04967.2003 · Cited by 337
Redford, E. (1997) · Brain · doi:10.1093/brain/120.12.2149 · Cited by 326
Lipid microarrays identify key mediators of autoimmune brain inflammation
Kanter, J. L., Narayana, S., Ho, P. P., Catz, I., Warren, K. G., Sobel, R. A., Steinman, L., & Robinson, W. H. (2006) · Nature Medicine · doi:10.1038/nm1344 · Cited by 317
Meinl, E., Krumbholz, M., & Hohlfeld, R. (2006) · Annals of Neurology · doi:10.1002/ana.20890 · Cited by 310
Self-citationTait, S., Gunn-Moore, F., Collinson, J. M., Huang, J., Lubetzki, C., Pedraza, L., Sherman, D. L., Colman, D. R., & Brophy, P. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.3.657 · Cited by 298
Charles, P., Tait, S., Faivre-Sarrailh, C., Barbin, G., Gunn-Moore, F., Denisenko-Nehrbass, N., Guennoc, A.-M., Girault, J.-A., Brophy, P. J., & Lubetzki, C. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00680-7 · Cited by 297
Morgan, B. P., Dankert, J. R., & Esser, A. F. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.1.246 · Cited by 255
The contribution of demyelination to axonal loss in multiple sclerosis
DeLuca, G. C. (2006) · Brain · doi:10.1093/brain/awl074 · Cited by 231
Zhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Brück, W., Hartung, H.-P., Stadelmann, C., & Hemmer, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607242103 · Cited by 231
Coman, I., Aigrot, M. S., Seilhean, D., Reynolds, R., Girault, J. A., Zalc, B., & Lubetzki, C. (2006) · Brain · doi:10.1093/brain/awl144 · Cited by 210
O'Hanlon, G. M. (2001) · Brain · doi:10.1093/brain/124.5.893 · Cited by 192
Howell, O. W., Palser, A., Polito, A., Melrose, S., Zonta, B., Scheiermann, C., Vora, A. J., Brophy, P. J., & Reynolds, R. (2006) · Brain · doi:10.1093/brain/awl290 · Cited by 183
Ratcliffe, C. F., Westenbroek, R. E., Curtis, R., & Catterall, W. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102086 · Cited by 173
Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
Stefferl, A., Schubart, A., Storch, M. K., Amini, A., Mather, I. H., Lassmann, H., & Linington, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2859 · Cited by 156
Self-citationSadatipour, B. T., Greer, J. M., & Pender, M. P. (1998) · Annals of Neurology · doi:10.1002/ana.410440621 · Cited by 140
Wolswijk, G., & Balesar, R. (2003) · Brain · doi:10.1093/brain/awg151 · Cited by 138
Leech, S., Kirk, J., Plumb, J., & McQuaid, S. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00781.x · Cited by 137
Eikelenboom, M. J., Petzold, A., Lazeron, R. H. C., Silber, E., Sharief, M. K., Thompson, E. J., Barkhof, F., Giovannoni, G., Polman, C. H., & Uitdehaag, B. M. J. (2003) · Neurology · doi:10.1212/01.wnl.0000041496.58127.e3 · Cited by 136
Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease
Ercolini, A. M., & Miller, S. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3293 · Cited by 95
Parry, A., Corkill, R., Blamire, A., Palace, J. A., Narayanan, S., Arnold, D., Styles, P., & Matthews, P. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0965-8 · Cited by 89
Intraneural activated T cells cause focal breakdown of the blood-nerve barrier
Spies, J. M., Westland, K. W., Bonner, J. G., & Pollard, J. D. (1995) · Brain · doi:10.1093/brain/118.4.857 · Cited by 77
Fas Ligand (CD95L) Protects Neurons Against Perforin- Mediated T Lymphocyte Cytotoxicity
Medana, I. M., Li, Z., Flügel, A., Tschopp, J., Wekerle, H., & Neumann, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.674 · Cited by 71
van Beek, J., van Meurs, M., Hart, B. A. ‘., Brok, H., Neal, J. W., Chatagner, A., Harris, C. L., Omidvar, N., Morgan, B. P., Laman, J. D., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2353 · Cited by 68
Acute demyelination disrupts the molecular organization of peripheral nervous system nodes
Arroyo, E. J., Sirkowski, E. E., Chitale, R. V., & Scherer, S. S. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20321 · Cited by 67
Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions
Zhang, Y., Da, R.-R., Hilgenberg, L. G. W., Tourtellotte, W. W., Sobel, R. A., Smith, M. A., Olek, M. J., Nagra, R. M., Gupta, S., van den Noort, S., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.006 · Cited by 56
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study
Lily, O., Palace, J. A., & Vincent, A. C. (2004) · Brain · doi:10.1093/brain/awh031 · Cited by 52
AZZI, G., Bernaudin, J., Bouchaud, C., Bellon, B., & Fleury‐Feith, J. (1990) · Biology of the Cell · doi:10.1111/j.1768-322x.1990.tb00890.x · Cited by 37
Immunoadsorption patients with multiple sclerosis: an open‐label pilot study
Moldenhauer, A. I. S., Haas, J., Wäscher, C., Derfuss, T. J., Hoffmann, K., Kiesewetter, H., & Salama, A. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01518.x · Cited by 30
Self-citationCryptic Axonal Antigens and Axonal Loss in Multiple Sclerosis
DeVries, G. H. (2004) · Neurochemical Research · doi:10.1007/s11064-004-6873-1 · Cited by 15
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
Metadata
- Authors
- Mathey, E. K., Derfuss, T., Storch, M. K., Williams, K. R., Hales, K., Woolley, D. R., Al-Hayani, A., Davies, S. N., Rasband, M. N., Olsson, T., Moldenhauer, A., Velhin, S., Hohlfeld, R., Meinl, E., & Linington, C.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-09-10
- Volume
- 204
- Issue
- 10
- Pages
- 2363-2372
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2141440491
- Cited by
- 390
- References
- 52
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.